Mirae Asset Global Investments
GSK icon

Mirae Asset Global Investments’s GSK GSK Stock Holding History

Mirae Asset Global Investments’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,449
Closed -$120K – 1651
2025
Q4 		$120K Buy
+2,449
New +$114K ﹤0.01% 1229
2019
Q4 		– Sell
-14,551
Closed -$777K – 1484
2019
Q3 		$777K Sell
14,551
-47,369
-77% -$2.44M 0.01% 999
2019
Q2 		$3.1M Hold
61,920
– – 0.02% 589
2019
Q1 		$3.23M Sell
61,920
-17,520
-22% -$875K 0.02% 516
2018
Q4 		$3.79M Buy
79,440
+21,120
+36% +$1.04M 0.03% 431
2018
Q3 		$2.93M Hold
58,320
– – 0.02% 550
2018
Q2 		$2.94M Hold
58,320
– – 0.04% 278
2018
Q1 		$2.85M Buy
58,320
+32,400
+125% +$1.51M 0.04% 295
2017
Q4 		$1.15M Sell
25,920
-43,717
-63% -$2.02M 0.02% 453
2017
Q3 		$3.54M Buy
69,637
+266
+0.4% +$13.5K 0.06% 223
2017
Q2 		$3.74M Buy
69,371
+31,421
+83% +$1.68M 0.07% 192
2017
Q1 		$2M Sell
37,950
-2,558
-6% -$130K 0.04% 281
2016
Q4 		$1.95M Buy
40,508
+70
+0.2% +$3.46K 0.04% 269
2016
Q3 		$2.18M Sell
40,438
-3,709
-8% -$203K 0.05% 236
2016
Q2 		$2.39M Buy
44,147
+1,175
+3% +$61.9K 0.06% 197
2016
Q1 		$2.18M Sell
42,972
-1,214
-3% -$60.5K 0.06% 205
2015
Q4 		$2.23M Buy
44,186
+4,426
+11% +$226K 0.07% 208
2015
Q3 		$1.91M Buy
39,760
+19,600
+97% +$1.02M 0.08% 204
2015
Q2 		$1.05M Buy
20,160
+14,640
+265% +$824K 0.03% 305
2015
Q1 		$318K Sell
5,520
-800
-13% -$45.9K 0.01% 405
2014
Q4 		$338K Sell
6,320
-26,640
-81% -$1.49M 0.01% 380
2014
Q3 		$1.89M Buy
32,960
+2,640
+9% +$162K 0.07% 174
2014
Q2 		$2.03M Buy
30,320
+1,360
+5% +$92.1K 0.05% 162
2014
Q1 		$1.93M Buy
28,960
+8,800
+44% +$595K 0.05% 160
2013
Q4 		$1.34M Buy
20,160
+160
+0.8% +$10.4K 0.06% 228
2013
Q3 		$1.25M Buy
20,000
+9,600
+92% +$618K 0.06% 215
2013
Q2 		$650K Buy
+10,400
New +$660K 0.03% 310

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Mirae Asset Global Investments's GSK Position: Q1 2026 in Review

Mirae Asset Global Investments sold out of GSK (GSK) in Q1 2026, closing a stake of 2,449 shares — an estimated $120K sold.

Mirae Asset Global Investments first reported a position in GSK in Q2 2013 and held it in 27 quarters. The position peaked at $3.79M in Q4 2018. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Mirae Asset Global Investments reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
  • Mirae Asset Global Investments sold 2,449 GSK shares in Q1 2026, an estimated $120K.
  • Mirae Asset Global Investments first reported a position in GSK in Q2 2013 and held it in 27 quarters.
  • Mirae Asset Global Investments's GSK position peaked at $3.79M in Q4 2018.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Mirae Asset Global Investments's 13F filing for Q1 2026, filed 4 May 2026.